157 related articles for article (PubMed ID: 37065467)
1. Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant
Kaul M; Ferrer-González E; Mark L; Parhi AK; LaVoie EJ; Pilch DS
Med Chem Res; 2022 Oct; 31(10):1705-1715. PubMed ID: 37065467
[TBL] [Abstract][Full Text] [Related]
2. Impact of FtsZ Inhibition on the Localization of the Penicillin Binding Proteins in Methicillin-Resistant Staphylococcus aureus.
Ferrer-González E; Huh H; Al-Tameemi HM; Boyd JM; Lee SH; Pilch DS
J Bacteriol; 2021 Jul; 203(16):e0020421. PubMed ID: 34031040
[TBL] [Abstract][Full Text] [Related]
3. Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant
Bryan E; Ferrer-González E; Sagong HY; Fujita J; Mark L; Kaul M; LaVoie EJ; Matsumura H; Pilch DS
ACS Chem Biol; 2023 Mar; 18(3):629-642. PubMed ID: 36854145
[TBL] [Abstract][Full Text] [Related]
4. Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus.
Kaul M; Mark L; Parhi AK; LaVoie EJ; Pilch DS
Antimicrob Agents Chemother; 2016 Jul; 60(7):4290-6. PubMed ID: 27161635
[TBL] [Abstract][Full Text] [Related]
5. β-Lactam Antibiotics with a High Affinity for PBP2 Act Synergistically with the FtsZ-Targeting Agent TXA707 against Methicillin-Resistant Staphylococcus aureus.
Ferrer-González E; Kaul M; Parhi AK; LaVoie EJ; Pilch DS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630190
[TBL] [Abstract][Full Text] [Related]
6. TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.
Kaul M; Mark L; Zhang Y; Parhi AK; Lyu YL; Pawlak J; Saravolatz S; Saravolatz LD; Weinstein MP; LaVoie EJ; Pilch DS
Antimicrob Agents Chemother; 2015 Aug; 59(8):4845-55. PubMed ID: 26033735
[TBL] [Abstract][Full Text] [Related]
7. Comparative Genomics of Borderline Oxacillin-Resistant Staphylococcus aureus Detected during a Pseudo-outbreak of Methicillin-Resistant S. aureus in a Neonatal Intensive Care Unit.
Sawhney SS; Ransom EM; Wallace MA; Reich PJ; Dantas G; Burnham CD
mBio; 2022 Feb; 13(1):e0319621. PubMed ID: 35038924
[TBL] [Abstract][Full Text] [Related]
8. Clinical test to detect mecA and antibiotic resistance in Staphylococcus aureus, based on novel biotechnological methods.
Shahmohammadi MR; Nahaei MR; Akbarzadeh A; Milani M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1464-8. PubMed ID: 25950954
[TBL] [Abstract][Full Text] [Related]
9. Clonal diversity and epidemiological characteristics of Staphylococcus aureus: high prevalence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) associated with clinical isolates in Brazil.
Andrade-Figueiredo M; Leal-Balbino TC
BMC Microbiol; 2016 Jun; 16(1):115. PubMed ID: 27325108
[TBL] [Abstract][Full Text] [Related]
10. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
Nodzo SR; Boyle KK; Frisch NB
J Arthroplasty; 2019 Jul; 34(7S):S302-S306. PubMed ID: 30745218
[TBL] [Abstract][Full Text] [Related]
11. Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro.
Goh S; Loeffler A; Lloyd DH; Nair SP; Good L
BMC Microbiol; 2015 Nov; 15():262. PubMed ID: 26560174
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of Methicillin-Resistant Staphylococcus aureus (MRSA) and Borderline Oxacillin Resistant Staphylococcus aureus (BORSA) in community and food of animal origin.
Zehra A; Gulzar M; Singh R; Kaur S; Gill JPS
FEMS Microbiol Lett; 2020 Dec; 367(23):. PubMed ID: 33278300
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial effects of green tea polyphenols on clinical isolates of methicillin-resistant Staphylococcus aureus.
Cho YS; Schiller NL; Oh KH
Curr Microbiol; 2008 Dec; 57(6):542-6. PubMed ID: 18781360
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of sodium new houttuyfonate alone and in combination with oxacillin or netilmicin against methicillin-resistant Staphylococcus aureus.
Lu X; Yang X; Li X; Lu Y; Ren Z; Zhao L; Hu X; Jiang J; You X
PLoS One; 2013; 8(7):e68053. PubMed ID: 23844154
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC
Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036
[TBL] [Abstract][Full Text] [Related]
17. Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor.
Lui HK; Gao W; Cheung KC; Jin WB; Sun N; Kan JWY; Wong ILK; Chiou J; Lin D; Chan EWC; Leung YC; Chan TH; Chen S; Chan KF; Wong KY
Eur J Med Chem; 2019 Feb; 163():95-115. PubMed ID: 30503946
[TBL] [Abstract][Full Text] [Related]
18. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
[TBL] [Abstract][Full Text] [Related]
19. Nontargeted metabolomics reveals differences in the metabolite profiling among methicillin-resistant and methicillin-susceptible
Liu J; Qi M; Yuan Z; Wong TY; Song X; Lam H
Mol Omics; 2022 Dec; 18(10):948-956. PubMed ID: 36218091
[No Abstract] [Full Text] [Related]
20. New erythromycin derivatives enhance β-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Li Z; He M; Dong X; Lin H; Ge H; Shen S; Li J; Ye RD; Chen D
Lett Appl Microbiol; 2015 Apr; 60(4):352-8. PubMed ID: 25588530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
